Cargando…

Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy

This multicenter retrospective study was conducted to evaluate the 1-year treatment outcome of photodynamic therapy (PDT) combined with anti-vascular endothelial growth factor (VEGF) therapy for pachychoroid neovasculopathy (PNV). A total of 42 eyes of 42 patients with treatment-naïve PNV who were t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miki, Akiko, Kusuhara, Sentaro, Otsuji, Tsuyoshi, Kawashima, Yu, Miki, Katsuaki, Imai, Hisanori, Nakamura, Makoto, Tsujikawa, Akitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987186/ https://www.ncbi.nlm.nih.gov/pubmed/33755678 http://dx.doi.org/10.1371/journal.pone.0248760

Ejemplares similares

Characteristics of pachychoroid neovasculopathy
por: Tagawa, Miho, et al.
Publicado: (2020)

Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy
por: Tanaka, Koji, et al.
Publicado: (2021)

Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor
por: Roy, Rupak, et al.
Publicado: (2019)

One-Year Outcome of Combination Therapy with Full or Reduced Photodynamic Therapy and One Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy
por: Sato-Akushichi, Miki, et al.
Publicado: (2022)

Pachychoroid neovasculopathy and age-related macular degeneration
por: Miyake, Masahiro, et al.
Publicado: (2015)

Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Choroidal caverns in pachychoroid neovasculopathy
por: Ayachit, Apoorva, et al.
Publicado: (2020)

Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy and Good Baseline Visual Acuity
por: Chubachi, Aya, et al.
Publicado: (2021)

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
por: Chubachi-Kamimura, Aya, et al.
Publicado: (2023)

Pachychoroid neovasculopathy in extramacular choroidal neovascularization
por: Gupta, Mrinali Patel, et al.
Publicado: (2016)

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019)

The implications of subretinal fluid in pachychoroid neovasculopathy
por: Lee, Geun Woo, et al.
Publicado: (2021)

Association of IL-4 with pachychoroid neovasculopathy
por: Baba, Takashi, et al.
Publicado: (2023)

Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization
por: Kamimura, Aya, et al.
Publicado: (2023)

Remodeling of macular vortex veins in pachychoroid neovasculopathy
por: Matsumoto, Hidetaka, et al.
Publicado: (2019)

Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy
por: Schworm, Benedikt, et al.
Publicado: (2021)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
por: Elfandi, Sufian, et al.
Publicado: (2021)

Multimodal Imaging in Pachychoroid Neovasculopathy: A Case Report
por: Biçer, Özlem, et al.
Publicado: (2018)

A Case of Best Disease Accompanied by Pachychoroid Neovasculopathy
por: Batıoğlu, Figen, et al.
Publicado: (2019)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
por: Yoon, Jihyun, et al.
Publicado: (2021)

Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
por: Yamada, Chizu, et al.
Publicado: (2022)

Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy
por: Matsumoto, Hidetaka, et al.
Publicado: (2021)

Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept
por: Schworm, Benedikt, et al.
Publicado: (2020)

Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
por: Kusuhara, Sentaro, et al.
Publicado: (2023)

Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
por: Yoon, Jihyun, et al.
Publicado: (2021)

A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy
por: Yanık, Özge, et al.
Publicado: (2022)

Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
por: Keidel, Leonie F., et al.
Publicado: (2021)

Progression of Subclinical Pachychoroid Neovasculopathy to an Active Neovascularization in the Presence of Acquired Vitelliform Lesions
por: Soman, Manoj, et al.
Publicado: (2021)

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration
por: Farvardin, Mohsen, et al.
Publicado: (2022)

Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy
por: Keidel, Leonie F., et al.
Publicado: (2023)

Cystotomy with or without fibrinogen clot removal for refractory cystoid macular edema secondary to branch retinal vein occlusion
por: Yamada, Hiroko, et al.
Publicado: (2021)

Autologous Scleral Pocket Technique for Ahmed Glaucoma Valve Implantation with Pars Plana Tube Insertion for Neovascular Glaucoma
por: Maki, Hitomi, et al.
Publicado: (2021)

Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration
por: Kishi, Maya, et al.
Publicado: (2023)

Usefulness of intraoperative optical coherence tomography to minimize the intraocular lens tilt during the intrascleral fixation: a clinical and experimental evaluation
por: Sotani, Yasuyuki, et al.
Publicado: (2023)

Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation
por: Kusuhara, Sentaro, et al.
Publicado: (2022)

Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2020)

Choroidal Morphology on Ultra-Widefield Indocyanine Green Angiography and Response to Aflibercept in Pachychoroid Neovasculopathy
por: Han, Su Yeon, et al.
Publicado: (2023)

Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration
por: Hirai, Hiromasa, et al.
Publicado: (2021)

The Contemporary Role of Photodynamic Therapy in the Treatment of Pachychoroid Diseases
por: Iu, Lawrence P. L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9oal56pe3srhv78mve5mjts13